Moving averages
Company profile
Ginkgo Bioworks Holdings (DNA) is a pioneering force in synthetic biology, leveraging advanced genetic engineering to create customized bioengineered organisms suitable for a wide range of sectors, including pharmaceuticals, agriculture, and industrial biotechnology. The company's innovative platform streamlines cellular design and manufacturing, positioning Ginkgo as a key player in addressing critical global challenges such as climate change and food security. With a strong focus on sustainable biotechnology solutions, Ginkgo is well-equipped to tap into the increasing market demand for bio-based alternatives, highlighting its potential for significant growth and transformative impact across various industries.
Similar stocks in Biotechnology
RSI alerts for DNA
Get an email the moment Ginkgo Bioworks Holdings crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 7:15 AM EDT